Other Names
Acetylcholine secretion, peripheral cholinergic neurotransmitter release, ACh exocytosis
Disease Roles
Neurodegenerative diseaseCardiovascular diseaseOther

Acetylcholine release from peripheral cholinergic nerve endings Overview

Acetylcholine release from peripheral cholinergic nerve endings refers to the biological process by which acetylcholine, a major neurotransmitter, is discharged from motor neurons and autonomic nerve fibers into synapses with muscles or glands. This release is tightly regulated by calcium influx, vesicle docking, and fusion proteins. The released acetylcholine binds to postsynaptic receptors, activating muscle contraction, glandular secretion, or modulating autonomic functions. Disruption or pharmacological manipulation of this process by toxins or drugs can lead to profound physiological effects, including paralysis, hyperactivity, or cardiovascular instability

Mechanism of Action

Inhibition (e.g., botulinum toxin prevents vesicular release of ACh)\nExcessive stimulation (e.g., black widow spider venom causes massive ACh release resulting in overstimulation)\nModulation (various drugs affect upstream regulation, such as voltage-gated calcium channel blockers, but are not used therapeutically for this purpose in humans)

Biological Functions

Signal transduction
Muscle contraction
Autonomic nervous system regulation
Glandular secretion

Disease Associations

Neurodegenerative disease
Cardiovascular disease
Other

Safety Considerations

  • Paralysis
  • Convulsions, muscle cramping
  • Autonomic dysfunction

Interacting Drugs

Botulinum toxin
Black widow spider venom
Some anticholinesterase drugs

Associated Biomarkers

Biomarker
Choline acetyltransferase
Acetylcholinesterase activity